There is a high demand to identify biomarkers specific to human cancers for screening, early detection, as well as new therapeutic targets. The capacity of these biomarkers to predict the existence, stages, and associated therapeutic efficacy of human cancers would enable improvements in the early diagnosis and survival of cancer patients.

In this White Paper "CD Markers for Cancer Research" you will learn about the importance of CD markers expression as diagnostic and prognostic factors for monitoring the progression of tumors.

Please submit the form to get this valuable white paper: